On-chip Mobility Shift Chip, 4-Sipper from Caliper Life Sciences

Mouse Anti-Human KRT4 Monoclonal Antibody, Unconjugated, Clone 5H5 from Abnova Corporation

Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation

...es ,High Quality, Functionally-Validated, Ion Chan...having a critical role in nerve and muscle functio...S and the heart. Drugs that modulate ion channels ...as neuropathic pain, cardiac arrhythmia, hypertens...

Biology Products:

Mouse Anti-Human KRT4 Monoclonal Antibody, Unconjugated, Clone 5H5 from Abnova Corporation Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation hKv1.5-CHO K1 Recombinant Cell Line from Upstate hERG-CHO K1 Recombinant Cell Line from Upstate

(Date:11/20/2009)... 19, 2009 The estimated 4.6 million Americans inv...eloping respiratory symptoms due to poor air quali...udy undertaken earlier this year by investigators ...y Medicine. , The studywhich polled more than 80...nt of individuals working in barns complained of c...

(Date:11/20/2009)... German . , In the current online issue of t...ie Eyerich and Dr. Kilian Eyerich together with th...tituto Dermopatico dell,Immacolata in Rome, presen...milestone on the way to developing new treatment m...iasis and allergic reactions and potentially also ...

(Date:11/20/2009)...y, researchers report that a class of heart medica...harmful, effect on the heart, depending on their m... the journal Circulation Research , found that be...eceptors on the heart muscle offer the most benefi...y the beta-receptors can actually undermine the st...

Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2 Discovery of new type of immune cells regulating inflammation in chronic diseases 2 Carvedilol shown to have unique characteristics among beta blockers 2 Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 1 Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 2 Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 1 Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 2 Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 3 Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 4 Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 5 Huge Potential Returns for Healthcare Innovators 50385 1

[0] Barn personnel experience higher-than-average rates of respiratory symptoms [0] Discovery of new type of immune cells regulating inflammation in chronic diseases [0] Carvedilol shown to have unique characteristics among beta blockers

... drug seems very promising on paper; things are,of...omerase inhibitors,to treat cancer; they are suppo...nitely) aspect of cancer cells. Yet, something in ... them to inhibit completely,the telomerase. What t...lse? Hell no! Look out for whats stopping the drug...

... with E.coli, can lead to urinary tract infections... , “We found out that UTIs may be caused by inges...bRoy, director of Penn State’s Gastroenteric Disea...ed, she noted. , Senior author, Dr. Lee W. Riley,...oli strains isolated from patients with UTIs were ...

...tory earlier ;,progress in this area is made in th...eding the slow (and tedious) process of gene,cloni...c). ,Devices the size of a pager now have greater ...entire room. Similar advances are being,made in th...rsity of,Houston, now allowing researchers to inex...

Other Biology News:Combination therapy boosts effectiveness of telomere-directed cancer cell death 2 Bacteria collection sheds light on urinary tract infections 2 Inexpensive, mass-produced genes core of synthetic biology advances at UH 2

Combination therapy boosts effectiveness of telomere-directed cancer cell death Bacteria collection sheds light on urinary tract infections Inexpensive, mass-produced genes core of synthetic biology advances at UH

(Date:11/18/2009)...NE, Calif., Nov. 18 Ma...imetry(TM) and Measure-Through Motion and Low-Perf...rance-based Uni.H.A., one of the largest healthcar...has signed a multi-year purchasing agreement for "... The agreement offers preferred contract pricing ...

(Date:11/18/2009)... NEW YORK, Nov. 18 Reportlinker.co...vailable in its catalogue. ,, Biotechnology R...tp://www.reportlinker.com/p0164375/Biotechnology-R...rce=prnewswire&utm_medium=pr&utm_campaign=...are complex chemical compounds used in a range of ...

(Date:11/18/2009)... Promega Corporation and SwitchGear Geno...A-protein interactions. , ...mega Corporation and SwitchGear Genomics announce ...ractions. Results of a study using the HaloCHIP&tr...monstrate the ability to correlate DNA binding eve...

(Date:11/18/2009)...111 significantly reduces key cardiac enzymes at m...esented at American Heart Association 2009 Scienti...e/ - Viron Therapeutics Inc., a biotechnology comp...g protein therapeutics derived from pathogens, tod...l evaluating VT-111 (Serp-1), an anti-inflammatory...

Breaking Biology Technology:Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8 Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2 Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2 Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3 Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4

[0] Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products [0] Reportlinker Adds Biotechnology Reagents - A Global Market Perspective [0] Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity [0] Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients

Products	On-chip Mobility Shift Chip, 4-Sipper from Caliper Life Sciences
Company	Caliper Life Sciences
Item	On-chip Mobility Shift Chip, 4-Sipper
Price
Description	Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms.
Info	Caliper Life Sciences Caliper Life Sciences 68 Elm St Hopkinton, MA 01748 Customer Service: 508-435-9500 Fax Number: 508-435-3439 Web Site: http://www.caliperls.com